GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Bio-Rad Laboratories Inc (NYSE:BIO.B) » Definitions » Book Value per Share

Bio-Rad Laboratories (Bio-Rad Laboratories) Book Value per Share : $306.51 (As of Dec. 2023)


View and export this data going back to 1999. Start your Free Trial

What is Bio-Rad Laboratories Book Value per Share?

Bio-Rad Laboratories's book value per share for the quarter that ended in Dec. 2023 was $306.51.

During the past 12 months, Bio-Rad Laboratories's average Book Value Per Share Growth Rate was -5.70% per year. During the past 3 years, the average Book Value Per Share Growth Rate was -2.50% per year. During the past 5 years, the average Book Value Per Share Growth Rate was 18.70% per year. During the past 10 years, the average Book Value Per Share Growth Rate was 21.30% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the book value growth rate using book value per share data.

During the past 13 years, the highest 3-Year average Book Value Per Share Growth Rate of Bio-Rad Laboratories was 50.20% per year. The lowest was -2.50% per year. And the median was 15.10% per year.

Bio-Rad Laboratories's current price is $279.91. Its book value per share for the quarter that ended in Dec. 2023 was $306.51. Hence, today's PB Ratio of Bio-Rad Laboratories is 0.91.

During the past 13 years, the highest P/B Ratio of Bio-Rad Laboratories was 2.81. The lowest was 0.90. And the median was 1.70.

Good Sign:

Bio-Rad Laboratories Inc stock PB Ratio (=0.9) is close to 10-year low of 0.9


Bio-Rad Laboratories Book Value per Share Historical Data

The historical data trend for Bio-Rad Laboratories's Book Value per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Bio-Rad Laboratories Book Value per Share Chart

Bio-Rad Laboratories Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Book Value per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 192.31 331.05 457.21 324.89 306.51

Bio-Rad Laboratories Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Book Value per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 324.89 329.76 290.51 288.77 306.51

Competitive Comparison of Bio-Rad Laboratories's Book Value per Share

For the Medical Devices subindustry, Bio-Rad Laboratories's PB Ratio, along with its competitors' market caps and PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Bio-Rad Laboratories's PB Ratio Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Bio-Rad Laboratories's PB Ratio distribution charts can be found below:

* The bar in red indicates where Bio-Rad Laboratories's PB Ratio falls into.



Bio-Rad Laboratories Book Value per Share Calculation

Bio-Rad Laboratories's Book Value Per Share for the fiscal year that ended in Dec. 2023 is calculated as:

Book Value Per Share=(Total Stockholders Equity-Preferred Stock)/Shares Outstanding (EOP)
=(8,741-0)/29
=306.51

Bio-Rad Laboratories's Book Value Per Share for the quarter that ended in Dec. 2023 is calculated as:

Book Value Per Share=(Total Stockholders Equity-Preferred Stock)/Shares Outstanding (EOP)
=(8,741-0)/29
=306.51

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Theoretically it is what the shareholders will receive if the company is liquidated. Total Stockholders Equity is a balance sheet item and equal to Total Assets less Total Liabilities of the company.

Book value may include intangible items which may come from the company's past acquisitions. Book value less intangibles is called Tangible Book.


Bio-Rad Laboratories  (NYSE:BIO.B) Book Value per Share Explanation

Usually a company's book value and Tangible Book per Share may not reflect its true value. The assets may be carried on the balance sheets at the original cost minus depreciation. This may underestimate the true economic values of the assets. It also may over-estimate their true economic value because the assets can become obsolete.

For financial companies such as banks and insurance companies, their assets may be reported in current market value of the assets owned. Book values of financial companies are more accurate indicator of the economic value of the company.


Bio-Rad Laboratories Book Value per Share Related Terms

Thank you for viewing the detailed overview of Bio-Rad Laboratories's Book Value per Share provided by GuruFocus.com. Please click on the following links to see related term pages.


Bio-Rad Laboratories (Bio-Rad Laboratories) Business Description

Traded in Other Exchanges
Address
1000 Alfred Nobel Drive, Hercules, CA, USA, 94547
Bio-Rad Laboratories, headquartered in Hercules, California, develops, manufactures, and markets products and solutions for the clinical diagnostics and life sciences markets. In diagnostics (53% of sales), Bio-Rad manufactures, sells, and supports test systems and specialized quality controls for clinical laboratories. In life sciences (47% of sales), the firm develops and manufactures a range of instruments and reagents used in research, biopharmaceutical production, and food testing. The company is geographically diverse, with major markets in the Americas, Europe and Africa , and Asia-Pacific. Bio-Rad owns 37% of Sartorius AG, a laboratory and biopharmaceutical supplier.